Crossmark

A Cost-Effectiveness Study Comparing Ready-to-Administer and Traditional Vial-and-Syringe Method for Opioids

Crossref DOI link: https://doi.org/10.1007/s40122-022-00402-z

Published Online: 2022-06-10

Published Print: 2022-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Arora, Prachi https://orcid.org/0000-0002-7057-9033
Muehrcke, Maria

Hertig, John
Funding

Funding for this research was provided by:

Fresenius Kabi
License Information

Text and Data Mining valid from 2022-06-10

Version of Record valid from 2022-06-10
More Information

Article History

Received: 8 April 2022

Accepted: 26 May 2022

First Online: 10 June 2022